A recent study finds that a new compound reverses many of the major symptoms associated with Fragile X syndrome (FXS),...
Boosts Sociability, Quells Repetitiveness – NIH Study National Institutes of Health researchers have reversed behaviors in mice resembling two of...
Scientists have now identified a specific dysfunction in neuronal circuits that is caused by autism. The scientists also report about their success in reversing these neuronal changes in mouse models.
Researchers upend a long-held view about the basic functioning of a key receptor molecule involved in signaling between neurons. The study describes how a compound linked to Alzheimer's disease impacts NMDA receptors and weakens synaptic connections between brain cells.
Using neuroimaging, researchers discovered glutamate levels are abnormally high in people with restless leg syndrome. The higher the level of glutamate in patients with RLS, the less sleep they were able to get.
Genetically engineered mice with a human gene for schizophrenia and who were exposed to lead early in life, exhibited behavioral and structural changes in the brain consistent with schizophrenia. Researchers believe their findings show a synergistic effect between lead exposure and the schizophrenia gene.
Researchers uncover clues about the biochemical pathway in the brain which could expand treatment options for schizophrenia.
Researchers have developed an experimental drug, NitroMemantine, to boost brain synapses lost in Alzheimer's disease. The drug stops the destructive cascade of brain changes which destroy connections between neurons that leads to memory loss and cognitive decline.
Researchers discover an enzyme, IDH, which facilitates the breakdown of specific amino acids makes glioblastoma brain cancer particularly aggressive.
A new study shows how reciprocal communication between different brain cells contributes to neuronal integrity.
Researchers discover the role protein mGluR5 plays in cocaine addiction. The finding could help point a way to new treatments for addiction.
Researchers discover three specific drugs affect three different kinds of neurotransmitter receptors which all appear to play roles in Fragile X.
